載入...
Current Standard and Investigational Approaches to the Management of Hormone-Refractory Prostate Cancer
Prostate cancer is a common cause of death in men and remains incurable in the metastatic setting. In 2004, 2 landmark trials using docetaxel-based chemotherapy, TAX 327 and SWOG 99-16, showed a survival benefit for the first time in metastatic, hormone-refractory prostate cancer. Current research s...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MedReviews, LLC
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1831542/ https://ncbi.nlm.nih.gov/pubmed/17387372 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|